Optimal acid suppression therapy in critically ill patients.
Pardi
D S
DS
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D011899:Ranitidine / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000517:prevention & control*; D013392:Sucralfate / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D013392:Sucralfate; D011899:Ranitidine; D009853:Omeprazole